MCID: CRS001
MIFTS: 39

Crescentic Glomerulonephritis malady

Category: Nephrological diseases

Aliases & Classifications for Crescentic Glomerulonephritis

About this section

Aliases & Descriptions for Crescentic Glomerulonephritis:

Name: Crescentic Glomerulonephritis 10 12
 
Idiopathic Crescentic Glomerulonephritis 65

Classifications:



External Ids:

Disease Ontology10 DOID:13139
SNOMED-CT59 236398000, 45406000
NCIt42 C35444
UMLS65 C0403416

Summaries for Crescentic Glomerulonephritis

About this section
MalaCards based summary: Crescentic Glomerulonephritis, also known as idiopathic crescentic glomerulonephritis, is related to thrombocytopenia and meconium aspiration syndrome. An important gene associated with Crescentic Glomerulonephritis is MPO (Myeloperoxidase), and among its related pathways are Immune response_MIF-mediated glucocorticoid regulation and IL-4 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types. Affiliated tissues include breast, prostate and t cells, and related mouse phenotypes are immune system and cardiovascular system.

Related Diseases for Crescentic Glomerulonephritis

About this section

Diseases related to Crescentic Glomerulonephritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 435)
idRelated DiseaseScoreTop Affiliating Genes
1thrombocytopenia30.6ICAM1, VCAM1
2meconium aspiration syndrome30.5ICAM1, MPO
3angioedema30.5ICAM1, MPO
4liver cirrhosis30.4ICAM1, VCAM1
5inferior myocardial infarction30.4ICAM1, VCAM1
6immune-complex glomerulonephritis30.3CCL2, CCR5
7ataxia30.3CTGF, ICAM1
8conduct disorder30.2ICAM1, MPO, VCAM1
9myocardial infarction29.6CCR5, CTGF, MPO, TFPI, VCAM1
10asthma29.3ICAM1, IL2RA, MPO, TGFB1, VCAM1
11rheumatoid arthritis29.3CCL2, ICAM1, IL2RA, TGFB1, VCAM1
12systemic lupus erythematosus29.2CCL2, ICAM1, IL2RA, VCAM1
13rapidly progressive glomerulonephritis11.7
14pauci-immune glomerulonephritis10.6
15pauci-immune glomerulonephritis without anca10.6
16pauci-immune glomerulonephritis with anca10.6
17leukemia10.5
18breast cancer10.4
19prostatitis10.4
20non-langerhans-cell histiocytosis10.4CCL2, CCR5
21neuronitis10.4
22endotheliitis10.4
23cerebellopontine angle primitive neuroectodermal10.3CCR5, MPO
24childhood kidney cell carcinoma10.3CCL2, ICAM1
25obesity10.3
26melanoma10.3
27adenoma10.3
28neuropathy10.3
29plasma cell neoplasm10.3ICAM1, VCAM1
30rhizomelic dysplasia patterson lowry type10.3ICAM1, VCAM1
31fetal erythroblastosis10.3MPO, SYNPO, TGFB1
32renal cell carcinoma10.3
33arthritis10.3
34hepatitis10.3
35pancreatitis10.3
36thyroiditis10.3
37cardiomyopathy10.3
38exudative glomerulonephritis10.3ICAM1, MPO, TGFB1
39pulmonary hypertension10.3CCL2, TGFB1
40episodic ataxia10.2CTGF, TGFB1
41tuberculoid leprosy10.2ICAM1, MPO, TGFB1
42clear cell squamous cell skin carcinoma10.2CCL2, MPO, TGFB1
43laryngeal tuberculosis10.2CTGF, TGFB1
44acute interstitial pneumonia10.2CCL2, ICAM1, TGFB1
45diffuse scleroderma10.2CCL2, ICAM1, TGFB1
46monckeberg arteriosclerosis10.2ICAM1, VCAM1
47fecal incontinence10.2SYNPO, WT1
48timothy grass allergy10.2ICAM1, MPO
49congenital diaphragmatic hernia10.2ICAM1, VCAM1
50colorectal cancer10.2

Graphical network of the top 20 diseases related to Crescentic Glomerulonephritis:



Diseases related to crescentic glomerulonephritis

Symptoms for Crescentic Glomerulonephritis

About this section

Drugs & Therapeutics for Crescentic Glomerulonephritis

About this section

Drugs for Crescentic Glomerulonephritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cyclophosphamideapproved, investigationalPhase 2, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
2
MethylprednisoloneapprovedPhase 2, Phase 3108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
PrednisoneapprovedPhase 2, Phase 3126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
4
PrednisoloneapprovedPhase 2, Phase 3108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
5Immunosuppressive AgentsPhase 2, Phase 310422
6Immunologic FactorsPhase 2, Phase 318483
7Immunoglobulin APhase 2, Phase 3110
8Prednisolone acetatePhase 2, Phase 31082
9AntiemeticsPhase 2, Phase 33213
10Peripheral Nervous System AgentsPhase 2, Phase 318510
11Protective AgentsPhase 2, Phase 35651
12Anti-Inflammatory AgentsPhase 2, Phase 38478
13Gastrointestinal AgentsPhase 2, Phase 36401
14Neuroprotective AgentsPhase 2, Phase 31376
15Prednisolone phosphatePhase 2, Phase 31082
16Prednisolone hemisuccinatePhase 2, Phase 31082
17Hormone AntagonistsPhase 2, Phase 310002
18glucocorticoidsPhase 2, Phase 33896
19Methylprednisolone HemisuccinatePhase 2, Phase 31082
20HormonesPhase 2, Phase 311748
21Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 2, Phase 39988
22Methylprednisolone acetatePhase 2, Phase 31082
23Antineoplastic Agents, HormonalPhase 2, Phase 34256
24
Lisinoprilapproved, investigationalPhase 211683915-83-75362119
Synonyms:
(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
76547-98-3
77726-95-5
83915-83-7 (Parent)
AC1NSFPF
Acerbon
Acercomp
Alapril
BB_NC-1454
BIDD:GT0755
BPBio1_000290
BRD-K67966701-335-03-5
BRN 4276619
BSPBio_000262
C21H31N3O5
CCRIS 3568
CHEBI:43755
CHEMBL1237
CID5362119
Carace
Cipral
Cipril
Coric
D08131
DB00722
DivK1c_001037
Doneka
EINECS 278-488-1
HMS1921B14
HMS2090O14
HMS2092L21
HMS503O15
I06-1895
ICI-209K
IDI1_001037
Inhibril
Inopril
KBio1_001037
KBio2_000977
KBio2_003545
KBio2_006113
KBio3_002002
KBioGR_001599
KBioSS_000977
L0220
LPR
LS-118899
Linopril
Linvas
Lipril
Lisinal
Lisinopril
Lisinopril (INN)
 
Lisinopril (anhydrous)
Lisinopril 10mg
Lisinopril 2.5mg
Lisinopril 20mg
Lisinopril 40mg
Lisinopril 5mg
Lisinopril Dihydrate
Lisinopril anhydrous
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
Lysinopril
MK 521
MK 522
MK-521
MLS001306436
MLS001306481
MolPort-002-507-428
N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline
N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
NCGC00179623-01
NINDS_001037
Noperten
Novatec
Presiten
Prestwick0_000301
Prestwick1_000301
Prestwick2_000301
Prestwick3_000301
Prinil
Prinivil
Prinzide
Renacor
SMR000544473
SPBio_001351
SPBio_002481
SPECTRUM1501217
Sinopril
Sinopryl
Spectrum2_001456
Spectrum3_000941
Spectrum4_001040
Spectrum5_000995
Spectrum_000497
TL8005499
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
Zestril (TN)
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
lisinopril
25Protease InhibitorsPhase 24558
26HIV Protease InhibitorsPhase 24558
27Antihypertensive AgentsPhase 23618
28Angiotensin-Converting Enzyme InhibitorsPhase 2634
29
Mycophenolate mofetilapproved, investigational898128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate Mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
30
Mycophenolic acidapproved89824280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
 
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic Acid
Mycophenolsaeure
Myfortic
31Antirheumatic Agents8496
32Antibiotics, Antitubercular5971
33Alkylating Agents3582
34Anti-Bacterial Agents9140
35Antineoplastic Agents, Alkylating3406

Interventional clinical trials:

idNameStatusNCT IDPhase
1Immunoadsorption in Anti-GBM Glomerulonephritis.Not yet recruitingNCT02765789Phase 4
2Trial of Plasma Exchange for Severe Crescentic IgA NEphropathyRecruitingNCT02647255Phase 2, Phase 3
3ACE-inhibitors in Extracapillary GlomerulonephritisRecruitingNCT02682459Phase 2
4Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA NephropathyCompletedNCT00301600

Search NIH Clinical Center for Crescentic Glomerulonephritis

Genetic Tests for Crescentic Glomerulonephritis

About this section

Anatomical Context for Crescentic Glomerulonephritis

About this section

MalaCards organs/tissues related to Crescentic Glomerulonephritis:

33
Breast, Prostate, T cells, Endothelial, Kidney, Liver, Bone

Animal Models for Crescentic Glomerulonephritis or affiliated genes

About this section

MGI Mouse Phenotypes related to Crescentic Glomerulonephritis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053876.9CCL2, CCR5, ICAM1, IL2RA, MPO, TFPI
2MP:00053856.7CCR5, CTGF, ICAM1, MPO, PTPRO, TFPI

Publications for Crescentic Glomerulonephritis

About this section

Articles related to Crescentic Glomerulonephritis:

(show top 50)    (show all 535)
idTitleAuthorsYear
1
Neuropathologic Associations of Learning and Memory in Primary Progressive Aphasia. (27183206)
2016
2
Identification of a GJA3 Mutation in a Large Family with Bilateral Congenital Cataract. (26683566)
2015
3
Unitary TRPV3 channel Ca2+ influx events elicit endothelium-dependent dilation of cerebral parenchymal arterioles. (26453324)
2015
4
The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy : Incidence of radioepidermitis and the dose-response relationship. (25200358)
2014
5
17-I^-Estradiol counteracts the effects of high frequency electromagnetic fields on trophoblastic connexins and integrins. (23819010)
2013
6
FTO T/A and peroxisome proliferator-activated receptor-I^ Pro12Ala polymorphisms but not ApoA1 -75 are associated with better response to lifestyle intervention in Brazilians at high cardiometabolic risk. (23438152)
2013
7
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. (23861361)
2013
8
Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis. (24284376)
2013
9
Endoscopic ligation of the patulous eustachian tube as treatment for autophony. (23070705)
2013
10
Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. (24109239)
2013
11
Hepatitis C virus NS3 inhibitors: current and future perspectives. (24282816)
2013
12
Correlation between distribution of muscle weakness, electrophysiological findings and CTG expansion in myotonic dystrophy. (24417793)
2013
13
A case of ruptured renal cortical arteriovenous malformation of the right testicular vein in hemorrhagic fever with renal syndrome. (23682233)
2013
14
Successful treatment of leiomyoma of the nipple with carbon dioxide laser. (23809584)
2013
15
Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes. (23071274)
2012
16
Intracranial cysts containing cerebrospinal fluid-like fluid: results of endoscopic neurosurgery in a series of 64 consecutive cases. (21311305)
2011
17
Use of the Hunt-Lawrence pouch in congenital microgastria--a report of 2 cases. (21034951)
2010
18
Reliability of clinical findings and magnetic resonance imaging for the diagnosis of chondromalacia patellae. (20360517)
2010
19
Suffering in silence: a qualitative meta-data-analysis of postpartum depression. (19302513)
2009
20
Simultaneous Occurrence of Glial Heterotopia and Meningocele in the Orbit with Clinical Anophthalmia and Neurological Anomalies. (19873947)
2009
21
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent. (19437532)
2009
22
Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis. (19557721)
2009
23
Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. (18022748)
2008
24
The clinical course of steroid-sensitive childhood nephrotic syndrome is associated with a functional IL12B promoter polymorphism. (18632587)
2008
25
Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription. (17018618)
2006
26
Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. (16543916)
2006
27
Hemoglobin H hydrops fetalis syndrome resulting from the association of the - -SEA deletion and the alphaQuong Szealpha mutation in a Chinese woman. (16104884)
2005
28
Thymidine phosphorylase and fluoropyrimidines efficacy: a Jekyll and Hyde story. (15032715)
2004
29
Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. (12126250)
2002
30
The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. (12192542)
2002
31
Hyperhomocystinemia and 677C T methylenetetrahydrofolate reductase polymorphism as a cardiovascular risk factor in childhood]. (12042167)
2002
32
CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. (11477541)
2001
33
Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves. (10925100)
2000
34
Interstitial deletion of 11q13 sequences in HeLa cells. (10959095)
2000
35
Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. (10211878)
1999
36
Experience with window formation technique for hydrocele. (10448242)
1999
37
Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation. (9543159)
1998
38
Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. (9079626)
1997
39
Calcium-phosphorus-magnesium homeostasis in women with threatened abortion]. (9296937)
1997
40
Methionine to glutamine substitutions in the C-terminal domain of calmodulin impair the activation of three protein kinases. (8940012)
1996
41
High resolution genetic map of the adenomatous polyposis coli gene (APC) region. (7604852)
1995
42
Repair of complete atrioventricular canal defects: results with the two-patch technique. (7677476)
1995
43
Serum growth hormone and somatomedin-C in patients with bilharzial hepatic fibrosis and post hepatitic cirrhosis. (2033287)
1991
44
Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy. (2927614)
1989
45
Neurophysiological measurements in patients with genuine stress incontinence of urine and the relation of neurogenic defects to the presence of spina bifida occulta. (3044478)
1988
46
Dispersed human immunoglobulin kappa light-chain genes. (3083265)
1986
47
Pulmonary manifestations of the yellow nail syndrome. (5046843)
1972
48
Transient lactose intolerance in premature infants. (5121241)
1971
49
50

Variations for Crescentic Glomerulonephritis

About this section

Expression for genes affiliated with Crescentic Glomerulonephritis

About this section
Search GEO for disease gene expression data for Crescentic Glomerulonephritis.

Pathways for genes affiliated with Crescentic Glomerulonephritis

About this section

GO Terms for genes affiliated with Crescentic Glomerulonephritis

About this section

Biological processes related to Crescentic Glomerulonephritis according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cellular extravasationGO:000269310.5CCL2, ICAM1
2positive regulation of collagen biosynthetic processGO:003296710.5CCL2, TGFB1
3organ regenerationGO:003110010.3CCL2, TGFB1
4leukocyte cell-cell adhesionGO:000715910.3ICAM1, VCAM1
5response to progesteroneGO:003257010.3CCL2, TGFB1
6glomerulus developmentGO:003283510.2PTPRO, WT1
7negative regulation of immune responseGO:005077710.1IL2RA, TGFB1
8negative regulation of T cell proliferationGO:004213010.1IL2RA, TGFB1
9lipopolysaccharide-mediated signaling pathwayGO:003166310.0CCL2, TGFB1
10cytokine-mediated signaling pathwayGO:00192219.9CCL2, ICAM1, VCAM1
11T cell homeostasisGO:00430299.9IL2RA, TGFB1
12agingGO:00075689.8CCL2, MPO, TGFB1
13cellular response to dexamethasone stimulusGO:00715499.8CCL2, TGFB1
14MAPK cascadeGO:00001659.6CCL2, CCR5, TGFB1
15cellular response to tumor necrosis factorGO:00713569.5CCL2, ICAM1, VCAM1
16response to woundingGO:00096119.4CCL2, CTGF, TGFB1
17extracellular matrix organizationGO:00301989.1ICAM1, TGFB1, VCAM1
18cell adhesionGO:00071558.7CCL2, CTGF, ICAM1, VCAM1

Sources for Crescentic Glomerulonephritis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet